Jeppsson et al. demonstrated that the combination of t-tau, Aß40, and MCP-1 separates iNPH patients from other cognitive and movement disorders, but the focus was not on predictive neurocognitive outcomes or even aspects of the Hakim Triad [15]. The gene discussed is CCL2; the disease is movement disorder.